The article discusses the effort of the government and representatives from the pharmaceutical industry to work out a voluntary system for the distribution of the Salk poliomyelitis vaccine in the U.S. It states that the allocation of the drug through commercial and noncommercial ways has become almost standard practice. It points on the failure of vaccine to match the supply with the demand.
Processing Request
No Comments.